TRACLEER for Pulmonary arterial hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,472 adverse event reports in the FDA FAERS database where TRACLEER was used for Pulmonary arterial hypertension.
Most Reported Side Effects for TRACLEER
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 382 | 20.5% | 382 | 85 |
| Dyspnoea | 229 | 12.3% | 64 | 201 |
| Pulmonary arterial hypertension | 127 | 6.8% | 85 | 70 |
| Pneumonia | 121 | 6.5% | 41 | 109 |
| Condition aggravated | 86 | 4.6% | 46 | 55 |
| Fall | 79 | 4.2% | 16 | 65 |
| Fluid retention | 65 | 3.5% | 20 | 60 |
| Dizziness | 63 | 3.4% | 10 | 57 |
| Cardiac failure congestive | 60 | 3.2% | 23 | 48 |
| Aspartate aminotransferase increased | 59 | 3.2% | 8 | 35 |
| Fatigue | 59 | 3.2% | 10 | 50 |
| Alanine aminotransferase increased | 57 | 3.1% | 8 | 33 |
| Malaise | 57 | 3.1% | 16 | 49 |
| Disease progression | 54 | 2.9% | 47 | 21 |
| Syncope | 54 | 2.9% | 11 | 48 |
Other Indications for TRACLEER
Pulmonary hypertension (116)
Cor pulmonale chronic (101)
Product used for unknown indication (86)
Skin ulcer (14)
Scleroderma associated digital ulcer (8)
Systemic lupus erythematosus (6)
Connective tissue disorder (5)
Scleroderma (5)
Systemic sclerosis (5)
Other Drugs Used for Pulmonary arterial hypertension
TREPROSTINIL (72,609)
MACITENTAN (29,246)
AMBRISENTAN (27,852)
BOSENTAN (12,387)
SELEXIPAG (11,861)
RIOCIGUAT (9,158)
EPOPROSTENOL (8,508)
TADALAFIL (7,679)
SILDENAFIL (5,239)
ILOPROST (2,828)